Kate Sheehan, a licensed clinical social worker and managing director of the UCLA Center for Child Anxiety Resilience Education and Support, has some survival tips for navigating the wait.
Elective hip and knee replacements may represent a significant source of potentially controllable healthcare spending, according to a March 13 Viewpoint article published in the Journal of the American Medical Association (JAMA) and authored by members of the Center for Health Advancement at the UCLA Fielding School of Public Health (FSPH).
The Great Recession, spanning 2008 to 2010, was associated with heightened cardiovascular risk factors, including increased blood pressure and glucose levels.The connections were especially pronounced among older homeowners and people still in the work force,
Recent statistics from the U.S. Centers for Disease Control and Prevention show that almost one-third of all childhood injuries are sports-related, and that more than half of those are preventable.
Paid Family Medical Leave: Healthier U.S. Families Within Our Reach, a new report by the WORLD Policy Analysis Center at the UCLA Fielding School of Public Health, provides evidence of the most effective approaches to paid family and medical leave using data from the experiences of states in the U.S. and high-income countries that have paid leave policies in place.
New research shows for the first time that exposure to green space during childhood is associated with beneficial structural changes in the developing brain.
A UCLA study explored the relationship between new drivers' skills to age, gender and playing organized sports or video games. The results suggest all novice drivers should undergo mandatory training, not just teenagers.
Age: Among males, the older the student, the worse his driving skills score.
UCLA researchers found that nearly all people diagnosed with uveal melanoma had a number of unmet psychological and health information needs, particularly during the first three months after their diagnoses. The study is the first prospective, longitudinal approach to examine supportive care needs among patients with this disease, and suggested more acute needs among people with uveal melanoma than people with other cancers.
UCLA researchers used fluorescent colored proteins to trace how cardiomyocytes — cells in heart muscle that enable it to pump blood — are produced in mouse embryos. The findings could eventually lead to methods for regenerating heart tissue in human adults.
In practice, policy and education, oral health care and primary health care have traditionally been considered separate. In an effort to change that, a group of public health dentists has issued recommendations on improving the integration of the two with a goal to influence policymakers, clinicians, educators and health researchers.
UCLA researchers have developed a way to use brain scans and machine learning — a form of artificial intelligence — to predict whether people with OCD will benefit from cognitive behavior therapy. The technique could help improve the overall success rate of cognitive behavioral therapy, and it could enable therapists to tailor treatment to each patient.
Scientists have identified a gene that may play a protective role in preventing heart disease. Their research revealed that the gene, called MeXis, acts within key cells inside clogged arteries to help remove excess cholesterol from blood vessels.
UCLA researchers, in collaboration with the University of Iowa, discovered the contribution of a specific gene in the proper development of blood cells that give rise to hematopoietic stem cells. The findings identify a potential target for the development of treatments for some types of leukemia, anemia and other blood disorders.
UCLA researchers have discovered the inner workings of a gene network that regulates the development of spinal motor neurons in the growing chicken and mouse embryo. The research also answers a long-standing question about why motor neurons, the nerve cells of the spinal cord that control muscle movement, form much faster than other types of neurons.
UCLA researchers Dr. Leonard Marks and Shyam Natarajan will lead a $3.1 million research project grant awarded by the National Institutes of Health to advance the adoption of a promising new technology to treat men with prostate cancer. By helping to increase the widespread use of the technique, known as MRI-guided focal laser ablation, the research has the potential to vastly improve treatment options and outcomes for patients with the disease.
Various UCLA Health physicians offer their expertise on topics related to the Winter Olympics 2018, such as coping with sports injuries and testing for banned substances; among others.
UCLA scientists found that boosting mice's cholesterol levels spurred intestinal stem cells to divide more quickly, enabling tumors to form faster. The study identifies a new drug target for colon cancer treatment.
The Centers for Disease Control and Prevention, Office of Minority Health and Health Equity has awarded a five-year, $2.7 million grant to the UCLA Fielding School of Public Health to launch a training program that will inspire undergraduate students to pursue careers in public health and strengthen the future public health workforce.
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014–15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help lower that figure for future flu seasons.
The UCLA School of Dentistry has received a $1.5 million grant from the state’s largest dental benefits provider, Delta Dental of California, to support launching a community-based clinical education program. The award, which will support UCLA student dentists to care for some of the most vulnerable patients in California, is the largest that Delta Dental has ever given a dental school.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have, for the first time, coaxed human stem cells to become sensory interneurons — the cells that give us our sense of touch. The new protocol could be a step toward stem cell–based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.
UCLA researchers have developed the first map of gene regulation in human neurogenesis, the process by which neural stem cells turn into brain cells and the cerebral cortex expands in size. The scientists identified factors that govern the growth of our brains and, in some cases, set the stage for several brain disorders that appear later in life
Researchers found that the brain’s inferior frontal cortex is more active in people who are more averse to harming others when facing difficult ethical choices
Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells. These engineered cells persisted for more than two years
A study by UCLA researchers reveals the cellular basis for how the hormone estrogen protects against damage to the central nervous system in people with multiple sclerosis
The Medicaid expansions for low-income parents that took place between 1996 and 2011 led to a 2.3 percent decrease in the uninsured rate among women who already had a child and became pregnant again, and a 7.9 percent decrease in the number of mothers who didn’t have insurance while they were pregnant.
Holiday travel forces people into often-crowded airplanes, automobiles and airports and the result can be a cold or other bug that dims the holiday cheer.
Dr. Rhonda Voskuhl, who directs UCLA’s multiple sclerosis program and holds the Jack H. Skirball Chair for Multiple Sclerosis Research, has been selected as the recipient of the Berlin Institute of Health’s Excellence Award for Sex and Gender Aspects in Health Research
UCLA researchers, after developing a mouse model of Friedreich’s ataxia that shows symptoms similar to patients, have found that many early symptoms of the disease are completely reversible when the genetic defect linked to the ataxia is reversed
UCLA scientists have developed a new strategy to efficiently isolate, mature and transplant skeletal muscle cells created from human pluripotent stem cells, which can produce all cell types of the body. The findings are a major step towards developing a stem cell replacement therapy for muscle diseases including Duchenne Muscular Dystrophy.
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks
An experimental blood test developed at UCLA that uses gene activity data from immune cells was 93 percent accurate in predicting survival rates for people with advanced heart failure who had surgery to implant mechanical circulatory support devices.
A new study has found that women who had received chemotherapy and/or radiation to treat breast cancer were more likely to have high levels of DNA damage and reduced activity of an enzyme involved in chromosome healing, compared to women who underwent surgery alone. The results suggest that some breast cancer survivors may be more vulnerable to biological changes associated with accelerated aging because of their prior treatment.
A UCLA study in collaboration with the California Institute of Technology (Caltech) shows that skin cancer cells could be chemically changed from within to reflexively alter gene expression patterns and intracellular pathways, which allows the cells to become resistant to targeted drugs.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered how high glucose levels - whether caused by diabetes or other factors - keep heart cells from maturing normally. Their findings help explain why babies born to women with diabetes are more likely to develop congenital heart disease.
Year-end is a great time to reflect on our health and endeavor to improve it. As we do so, it's important to identify the steps that could have a big impact on our wellness.
Sunitinib (marketed as Sutent) a drug that has already proven highly effective as first-line treatment for people with metastatic renal cell carcinoma, was recently approved by the U.S. Food and Drug Administration to also treat patients with the disease who are at high risk for tumor recurrence.